Global Pessary Market size and share is currently valued at USD 421.97 million in 2023 and is anticipated to generate an estimated revenue of USD 636.32 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032.
The global pessary market is undergoing significant growth, driven by rising cases of pelvic organ prolapse and urinary incontinence among aging populations and increasing awareness of non-surgical treatment alternatives. A pessary, a medical device inserted into the vagina to support the pelvic organs, is an effective and minimally invasive option for managing a range of gynecological conditions. As the demand for conservative treatment methods increases, the pessary market is emerging as a vital component of women’s health solutions worldwide.
Market Overview
Pessaries have been used for centuries, but recent advancements in materials, design, and clinical practice have elevated their importance in modern gynecological care. These devices come in various shapes and sizes, including ring, Gellhorn, cube, and donut pessaries, each designed to address specific anatomical and functional needs.
Most commonly, pessaries are prescribed to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), conditions that significantly affect women’s quality of life, particularly in postmenopausal and postpartum populations. The market serves both therapeutic and preventive purposes, offering an accessible and reversible option for patients who wish to delay or avoid surgery.
In clinical practice, pessaries are typically managed on an outpatient basis. This ease of use, combined with improved patient education and follow-up care, is making pessary treatment increasingly popular among both patients and healthcare providers. Moreover, the growing involvement of nurse practitioners and primary care providers in pessary fitting and maintenance is expanding access to this treatment option beyond traditional gynecology clinics.
Key Companies:
- Bioteque America
- Bliss GVS Pharma
- CooperSurgical Inc.
- Dr. Arabin GmbH & Co. KG
- Integra LifeSciences
- MedGyn
- Panpac Medical Corporation
- Personal Medical Corporation
- Wallach Surgical Devices
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/pessary-market
Polaris Market Research has segmented the pessary market report based on type, end use.
Pessary, Type Outlook (Revenue – USD Million, 2023 – 2032)
- Gellhorn
- Ring
- Donut
- Others
Pessary, End Use Outlook (Revenue – USD Million, 2023 – 2032)
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Key Market Growth Drivers
- Rising Prevalence of Pelvic Floor Disorders
The global increase in pelvic floor disorders such as pelvic organ prolapse and urinary incontinence is a major factor driving the pessary market. Aging populations, obesity, and multiple childbirths are common risk factors contributing to these conditions. As these disorders become more widely recognized and diagnosed, the need for conservative, low-risk treatment options like pessaries is rising rapidly. - Preference for Non-Surgical and Reversible Treatments
A significant segment of women affected by POP or SUI prefers non-surgical management due to concerns about surgical risks, recovery time, and potential complications. Pessaries provide an effective alternative, offering symptom relief without the need for invasive intervention. The reversible nature of the treatment also makes it attractive for women who may be considering surgery in the future but are not ready or eligible at present. - Improved Product Design and Material Innovation
Recent innovations in the materials used to manufacture pessaries—such as medical-grade silicone—have enhanced the comfort, durability, and safety of these devices. Additionally, new shapes and sizes are being introduced to improve anatomical fit and function. These advancements have led to higher patient satisfaction and compliance, thereby supporting broader adoption. - Growing Awareness and Screening
Awareness campaigns and improved screening for pelvic floor conditions have significantly increased diagnosis rates. With greater public and professional attention on women’s pelvic health, more women are seeking treatment, including conservative options like pessary use. Education initiatives led by healthcare organizations and advocacy groups are helping to destigmatize pelvic health conditions and encourage early intervention. - Increased Role of Primary Care in Women’s Health
As primary care practitioners and nurse midwives become more involved in women’s health, they are also playing a larger role in the prescription and fitting of pessaries. This decentralization of care is making pessary services more accessible, especially in regions with limited access to specialist gynecological services.
Regional Analysis
- North America
North America leads the global pessary market due to high awareness of pelvic floor disorders, advanced healthcare infrastructure, and favorable reimbursement policies. The U.S. sees high demand for both diagnosis and conservative management of POP and SUI. The presence of well-established manufacturers and specialized healthcare providers further supports market growth in the region. - Europe
Europe represents a mature and steadily growing market for pessaries, with countries like Germany, the UK, and France showing strong demand. The region benefits from a well-developed healthcare system and increasing patient preference for non-invasive treatments. Continued efforts in patient education and training programs for healthcare providers are also fueling growth. - Asia-Pacific
Asia-Pacific is emerging as a key growth region, fueled by a large population base, improving healthcare access, and rising awareness of women’s health issues. Countries such as China, India, and Japan are seeing increased screening and diagnosis of pelvic floor disorders. Additionally, growing investments in healthcare infrastructure and training are expanding the reach of conservative gynecological treatments. - Latin America
In Latin America, the pessary market is gradually gaining momentum as awareness and acceptance of non-surgical treatments increase. Countries like Brazil and Mexico are seeing an uptick in demand due to growing gynecological service networks and educational outreach. Efforts to integrate pessary services into broader women’s health programs are beginning to show positive results. - Middle East & Africa
Although still at a nascent stage, the pessary market in the Middle East and Africa shows promising potential. Improvements in healthcare delivery and a growing focus on women’s reproductive health are expected to drive demand. Pilot programs and NGO-led initiatives are helping to bridge knowledge and access gaps in remote areas.
Market Outlook
The future of the pessary market appears optimistic, with sustained growth expected across all major regions. As the demand for patient-centered and non-invasive gynecological care increases, the use of pessaries is projected to become more widespread. Manufacturers are likely to focus on innovation, developing devices that cater to diverse anatomical and cultural needs. Training and support for healthcare providers will also be critical to ensure correct fitting and patient management.
With the growing recognition of pelvic floor disorders and the advantages of conservative treatment, the pessary market is positioned to play an increasingly vital role in women’s healthcare. Emphasizing accessibility, education, and product refinement will be key to expanding the market and improving outcomes for millions of women worldwide.
More Trending Latest Reports By Polaris Market Research:
Ready To Drink Tea And Coffee Market